Education
About Us
Working with TipRanks
Follow Us
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
RESEARCH TOOLSreports
MDMA Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.07 - C$0.34
Previous CloseN/A
Volume63.47K
Average Volume (3M)252.49K
Market Cap
C$11.10M
Enterprise ValueC$3.30M
Total Cash (Recent Filing)C$1.51M
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Aug 05, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding105,682,710
10 Day Avg. Volume524,899
30 Day Avg. Volume252,489
Financial Highlights & Ratios
PEG Ratio1.05
Price to Book (P/B)13.44
Price to Sales (P/S)0.00
P/FCF Ratio-21.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PharmAla Biotech Holdings, Inc. News
PremiumCompany Announcements
PharmAla Biotech Unveils AI Platform for Novel Drug Discovery
PremiumCompany Announcements
PharmAla Biotech Warns Against Counterfeit Products
PremiumCompany Announcements
PharmAla Biotech Expands MDMA Research and Market Reach with Yale Shipment
PremiumCompany Announcements
PharmAla Biotech Warns Against Counterfeit Products
PremiumCompany Announcements
PharmAla Biotech Unveils AI Platform for Novel Drug Discovery
PremiumCompany Announcements
PharmAla Biotech Reports Strong Q2 Growth and Strategic Advancements
Options Prices
Currently, No data available
---
Ownership Overview
9.69% Insiders
―
Mutual Funds
― Other Institutional Investors
90.31% Public Companies and
Individual Investors
MDMA FAQ
What was PharmAla Biotech Holdings, Inc.’s price range in the past 12 months?
PharmAla Biotech Holdings, Inc. lowest stock price was C$0.07 and its highest was C$0.34 in the past 12 months.
What is PharmAla Biotech Holdings, Inc.’s market cap?
PharmAla Biotech Holdings, Inc.’s market cap is C$11.10M.
When is PharmAla Biotech Holdings, Inc.’s upcoming earnings report date?
PharmAla Biotech Holdings, Inc.’s upcoming earnings report date is Aug 05, 2025 which is in 53 days.
How were PharmAla Biotech Holdings, Inc.’s earnings last quarter?
PharmAla Biotech Holdings, Inc. released its earnings results on May 05, 2025. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
Is PharmAla Biotech Holdings, Inc. overvalued?
According to Wall Street analysts PharmAla Biotech Holdings, Inc.’s price is currently Overvalued.
Does PharmAla Biotech Holdings, Inc. pay dividends?
PharmAla Biotech Holdings, Inc. does not currently pay dividends.
What is PharmAla Biotech Holdings, Inc.’s EPS estimate?
PharmAla Biotech Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PharmAla Biotech Holdings, Inc. have?
PharmAla Biotech Holdings, Inc. has 105,682,710 shares outstanding.
What happened to PharmAla Biotech Holdings, Inc.’s price movement after its last earnings report?
PharmAla Biotech Holdings, Inc. reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PharmAla Biotech Holdings, Inc.?
Currently, no hedge funds are holding shares in TSE:MDMA
Company Description
PharmAla Biotech Holdings, Inc.
Pharmala Biotech Holdings Inc., doing business as PharmAla, focuses on the developing, manufacturing, and commercializing of substituted methylenedioxy-phenethylamines (MDXX) active pharmaceutical ingredients. It also provides MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB); and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), as well as formulations of MDXX compounds. The company is headquartered in Vancouver, Canada.
Technical Analysis
Wesana Health Holdings Inc
―
HAVN Life Sciences
―
Marvel Biosciences Corp
―
Lexston Life Sciences Corp.
―
Lophos Holdings, Inc.
―